Research suggests that Epithalon may support cellular function by influencing mechanisms associated with healthy aging and cellular maintenance
Combination therapy: When combined with semaglutide 2.4 mg (CagriSema), phase 3 REDEFINE trials showed approximately 20% weight loss at 68 weeks, exceeding results with either agent alone [5] [12]
Strong provider-education program with CE-accredited training on peptide therapy for clinicians
Paracetamol (Acetaminophen) Administration During Neonatal Brain Development Affects Cognitive Function and Alters Its Analgesic and Anxiolytic Response in Adult Male Mice
Magnesium activates GABA receptors, the main inhibitory neurotransmitter system that promotes sleep
Suzanne Craft, Mitzi Gonzales, James Kirkland, Nicolas Musi, Ronald Petersen, Sudha Seshadri and Tamara Tchkonia for their significant contributions to the Phase 2 study design of SToMP-AD, and their ongoing collaborative support as co-investigators on the trial (NCT04685590)